Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0362 Transporter Info | ||||
Gene Name | SLC43A3 | ||||
Transporter Name | Equilibrative nucleobase transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
ATF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-3 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
CEBPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [2] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein alpha | Transcription Factor Info | ||||
Tissue |
Blood; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein alpha (CEBPA) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [3] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Blood; Breast; Cervix; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
CEBPD |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [4] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein delta | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein delta (CEBPD) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Blood; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
FOSL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [1] | ||||
TF Protein Name |
Fos-related antigen 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Fos-related antigen 1 (FOSL1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
JUNB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [2] | ||||
TF Protein Name |
Transcription factor JunB | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor JunB (JUNB) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
BHLHE40 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [4] | ||||
TF Protein Name |
Class E basic helix-loop-helix protein 40 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Class E basic helix-loop-helix protein 40 (BHLHE40) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
EPAS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [2] | ||||
TF Protein Name |
Endothelial PAS domain-containing protein 1 | Transcription Factor Info | ||||
Tissue |
Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Endothelial PAS domain-containing protein 1 (EPAS1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
LYL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [3] | ||||
TF Protein Name |
Protein lyl-1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein lyl-1 (LYL1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
MITF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC43A3 gene in melanoma condition | [5] | ||||
TF Protein Name |
Microphthalmia-associated transcription factor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Microphthalmia-associated transcription factor (MITF) has been reported to activate the transcription of SLC43A3 gene in melanoma condition, which leads to an increased expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
MYC |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC43A3 gene in Burkitt lymphoma condition | [6] | ||||
TF Protein Name |
Myc proto-oncogene protein | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Myc proto-oncogene protein (MYC) has been reported to repress the transcription of SLC43A3 gene in Burkitt lymphoma condition, which leads to a decreased expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC43A3 gene | [3] | ||||
TF Protein Name |
Myc proto-oncogene protein | Transcription Factor Info | ||||
Tissue |
Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc proto-oncogene protein (MYC) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
TCF21 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC43A3 gene in Coronary Artery Disease (CAD) condition | [7] | ||||
TF Protein Name |
Transcription factor 21 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor 21 (TCF21) has been reported to bind to the SLC43A3 gene in Coronary Artery Disease (CAD) condition, which affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
HNF4A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [8] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
NR1H3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC43A3 gene in atherosclerotic condition | [9] | ||||
TF Protein Name |
Oxysterols receptor LXR-alpha | Transcription Factor Info | ||||
Affected Drug/Substrate |
T0901317 | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Oxysterols receptor LXR-alpha (NR1H3) has been reported to activate the transcription of SLC43A3 gene in atherosclerotic condition, which leads to an increased expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
PPARD |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC43A3 gene in myofibroblasts condition | [10] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor delta | Transcription Factor Info | ||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Peroxisome proliferator-activated receptor delta (PPARD) has been reported to activate the transcription of SLC43A3 gene in myofibroblasts condition, which leads to an increased expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
RXRG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [1] | ||||
TF Protein Name |
Retinoic acid receptor RXR-gamma | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Retinoic acid receptor RXR-gamma (RXRG) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC43A3 gene in hematopoiesis condition | [11] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Erythroid transcription factor (GATA1) has been reported to bind to the transcription of SLC43A3 gene in hematopoiesis condition, which leads to an affected expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Transcriptional Phenomenon2 |
Activation of SLC43A3 gene in health condition | [12] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Erythroid transcription factor (GATA1) has been reported to activate the transcription of SLC43A3 gene in health condition, which leads to an increased expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Transcriptional Phenomenon3 |
Direct binding to SLC43A3 gene | [2] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
GATA2 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC43A3 gene in hematopoiesis condition | [11] | ||||
TF Protein Name |
Endothelial transcription factor GATA-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Endothelial transcription factor GATA-2 (GATA2) has been reported to bind to the transcription of SLC43A3 gene in hematopoiesis condition, which leads to an affected expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC43A3 gene | [3] | ||||
TF Protein Name |
Endothelial transcription factor GATA-2 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Endothelial transcription factor GATA-2 (GATA2) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
GATA3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [4] | ||||
TF Protein Name |
Trans-acting T-cell-specific transcription factor GATA-3 | Transcription Factor Info | ||||
Tissue |
Blood; Breast; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Trans-acting T-cell-specific transcription factor GATA-3 (GATA3) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
BCL6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC43A3 gene in CMLJURLMK1 condition | [13] | ||||
TF Protein Name |
B-cell lymphoma 6 protein | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
B-cell lymphoma 6 protein (BCL6) has been reported to activate the transcription of SLC43A3 gene in CMLJURLMK1 condition, which leads to an increased expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
EGR1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [1] | ||||
TF Protein Name |
Early growth response protein 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Early growth response protein 1 (EGR1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
KLF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [1] | ||||
TF Protein Name |
Krueppel-like factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 1 (KLF1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
KLF5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [4] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Tissue |
Pancreatic ductal; Stomach | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [2] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
SALL4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC43A3 gene in health condition | [14] | ||||
TF Protein Name |
Sal-like protein 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Sal-like protein 4 (SALL4) has been reported to activate the transcription of SLC43A3 gene in health condition, which leads to an increased expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
ZBTB7A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [3] | ||||
TF Protein Name |
Zinc finger and BTB domain-containing protein 7A | Transcription Factor Info | ||||
Tissue |
Bone marrow; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger and BTB domain-containing protein 7A (ZBTB7A) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
PBX1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC43A3 gene in ovarian cancer condition | [15] | ||||
TF Protein Name |
Pre-B-cell leukemia transcription factor 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Pre-B-cell leukemia transcription factor 1 (PBX1) has been reported to activate the transcription of SLC43A3 gene in ovarian cancer condition, which leads to an increased expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC43A3 gene | [3] | ||||
TF Protein Name |
Pre-B-cell leukemia transcription factor 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Pre-B-cell leukemia transcription factor 1 (PBX1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
POU2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [4] | ||||
TF Protein Name |
POU domain, class 2, transcription factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
POU domain, class 2, transcription factor 1 (POU2F1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
ZEB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [2] | ||||
TF Protein Name |
Zinc finger E-box-binding homeobox 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger E-box-binding homeobox 1 (ZEB1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
E2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [4] | ||||
TF Protein Name |
Transcription factor E2F1 | Transcription Factor Info | ||||
Tissue |
Mesenchymal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F1 (E2F1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
E2F3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [3] | ||||
TF Protein Name |
Transcription factor E2F3 | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F3 (E2F3) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
E2F4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC43A3 gene in health condition | [16] | ||||
TF Protein Name |
Transcription factor E2F4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor E2F4 (E2F4) has been reported to bind to the transcription of SLC43A3 gene in health condition, which leads to an affected expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
E2F6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [1] | ||||
TF Protein Name |
Transcription factor E2F6 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F6 (E2F6) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
FOXA1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC43A3 gene in prostate cancer condition | [17] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) has been reported to bind to the transcription of SLC43A3 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC43A3 gene | [4] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Embryo; Liver; Lung; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
TFDP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [2] | ||||
TF Protein Name |
Transcription factor Dp-1 | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor Dp-1 (TFDP1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Class3.4: Heat shock factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
HSF2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [4] | ||||
TF Protein Name |
Heat shock factor protein 2 | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Heat shock factor protein 2 (HSF2) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 9 TF(s) Regulating This DT |
|||||
ELF1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC43A3 gene | [18] | ||||
TF Protein Name |
ETS-related transcription factor Elf-1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
ETS-related transcription factor Elf-1 (ELF1) has been reported to bind to the transcription of SLC43A3 gene in . condition, which leads to a affected expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC43A3 gene | [4] | ||||
TF Protein Name |
ETS-related transcription factor Elf-1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Mesenchymal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
ETS-related transcription factor Elf-1 (ELF1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
ELK3 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC43A3 gene in hypoxia condition | [19] | ||||
TF Protein Name |
ETS domain-containing protein Elk-3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
ETS domain-containing protein Elk-3 (ELK3) has been reported to bind to the transcription of SLC43A3 gene in hypoxia condition, which leads to an affected expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC43A3 gene | [1] | ||||
TF Protein Name |
ETS domain-containing protein Elk-3 | Transcription Factor Info | ||||
Tissue |
Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
ETS domain-containing protein Elk-3 (ELK3) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
ERG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [2] | ||||
TF Protein Name |
Transcriptional regulator ERG | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional regulator ERG (ERG) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
ETS1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [3] | ||||
TF Protein Name |
Protein C-ets-1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone; Bone marrow; Kidney; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein C-ets-1 (ETS1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [2] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Umbilical cord blood; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [3] | ||||
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
Tissue |
Blood; Bone; Bone marrow; Brain; Liver; Mesenchymal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
IRF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [1] | ||||
TF Protein Name |
Interferon regulatory factor 4 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 4 (IRF4) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
MYB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [1] | ||||
TF Protein Name |
Transcriptional activator Myb | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional activator Myb (MYB) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
SPI1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC43A3 gene in APL condition | [20] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) has been reported to bind to the transcription of SLC43A3 gene in acute promyelocytic leukemia (APL) condition, which leads to an affected expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC43A3 gene | [1] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Tissue |
Adrenal gland; Blood; Bone marrow; Brain; Breast; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Placenta; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Class3.7: ARID domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
KDM5B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [2] | ||||
TF Protein Name |
Lysine-specific demethylase 5B | Transcription Factor Info | ||||
Tissue |
Bone marrow; Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Lysine-specific demethylase 5B (KDM5B) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Class4.1: High-mobility group domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SOX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC43A3 gene in colorectal cancer condition | [21] | ||||
TF Protein Name |
Transcription factor SOX-2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor SOX-2 (SOX2) has been reported to activate the transcription of SLC43A3 gene in colorectal cancer condition, which leads to an increased expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Class6.1: Rel homology region factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
EBF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [3] | ||||
TF Protein Name |
Transcription factor COE1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor COE1 (EBF1) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
RUNX1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC43A3 gene in health condition | [22] | ||||
TF Protein Name |
Runt-related transcription factor 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Runt-related transcription factor 1 (RUNX1) has been reported to bind to the transcription of SLC43A3 gene in health condition, which leads to an affected expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
Transcriptional Phenomenon2 |
Binding to SLC43A3 gene in megakaryocytes condition | [23] | ||||
TF Protein Name |
Runt-related transcription factor 1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Runt-related transcription factor 1 (RUNX1) has been reported to bind to the transcription of SLC43A3 gene in megakaryocytes condition, which leads to a affected expression of the drug transporter Equilibrative nucleobase transporter 1. | |||||
RUNX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC43A3 gene | [4] | ||||
TF Protein Name |
Runt-related transcription factor 2 | Transcription Factor Info | ||||
Tissue |
Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Runt-related transcription factor 2 (RUNX2) can directly bind to the SLC43A3 gene, which in turn affects the expression or function of the drug transporter Equilibrative nucleobase transporter 1. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.